tiprankstipranks
Kintara Therapeutics Seeks Approval for Key Merger with TuHURA Biosciences
Company Announcements

Kintara Therapeutics Seeks Approval for Key Merger with TuHURA Biosciences

Don't Miss Our Christmas Offers:

Kintara Therapeutics ( (KTRA) ) has provided an announcement.

Kintara Therapeutics, Inc. is urging stockholders to vote on a crucial merger with TuHURA Biosciences, emphasizing the vote’s significance for the company’s future in developing cancer therapies. The vote, needed to approve the merger, is set to take place at a Special Meeting of Stockholders on September 20, 2024. Stockholders are encouraged to vote by September 19. Kintara’s CEO highlights the merger’s potential to combine oncology assets and technologies, backed by substantial financing, to advance their pipeline and combat solid tumor cancers.

See more data about KTRA stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyKintara Therapeutics Inc trading halted, news pending
TipRanks Canadian Auto-Generated NewsdeskKintara Therapeutics Announces Stock Split Amid Merger
TheFlyKintara announces 1-for-35 reverse stock split in connection with TuHURA merger
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App